SCHEMBL3661247

SCHEMBL3661247

CN(C[C@H](CO)c1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 2/20 0.41
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
HTR2C P28335 2/20 0.38
SLC6A4 P31645 2/20 0.38
PRKCA P17252 1/20 0.38
PRKCD Q05655 1/20 0.38
CTSS P25774 2/20 0.38
CTSK P43235 1/20 0.38
GPR88 Q9GZN0 1/20 0.38
GAA P10253 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
MAPT P10636 1/20 0.38
AURKA O14965 1/20 0.37
RPS6KB1 P23443 1/20 0.37
MEN1 O00255 1/20 0.37
CRHBP P24387 1/20 0.37
KMT2A Q03164 1/20 0.37
CRHR2 Q13324 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23334606 1.00 CCR5 (0.41) CCR5KDM4EATMHTR2CSLC6A4
SCHEMBL8007152 0.85 TACR1 (0.49) CCR5KDM4EATMHTR2CSLC6A4
SCHEMBL3722932 0.82 AOC3 (0.50) KDM4EATMSLC6A4MEN1KMT2A
SCHEMBL20611086 0.82 AOC3 (0.50) KDM4EATMSLC6A4MEN1KMT2A
SCHEMBL23699426 0.81 CYP2C19 (0.41) CCR5KDM4EATMHTR2CSLC6A4
SCHEMBL1529744 0.81 AURKA (0.42) CCR5KDM4EATMHTR2CSLC6A4
SCHEMBL23303255 0.80 HPGD (0.42) CCR5KDM4EATMGAAMEN1
SCHEMBL17354850 0.79 CCR5 (0.40) CCR5KDM4EATMHTR2CSLC6A4
SCHEMBL14686241 0.79 KDM4E (0.39) CCR5KDM4EATMHTR2CSLC6A4
SCHEMBL23699048 0.78 MME (0.40) KDM4EATMHTR2CSLC6A4CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217549-A2 COMPOUNDS FOR USE IN IMAGING, DIAGNOSING, AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS Bayer Schering Pharma Aktiengesellschaft (DE) 2010-08-18 EP disclosed
WO-2009052970-A2 COMPOUNDS FOR USE IN IMAGING, DIAGNOSING, AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-04-30 WO disclosed